Straub H
Medizinische Universitätsklinik und Poliklinik, Bergmannsheil Bochum.
Aktuelle Traumatol. 1989 Feb;19(1):1-5.
The need for providing for a prophylaxis against thrombosis in surgery is now generally acknowledged in view of a basic risk of 10-60% thromboses and 1-5% fatal pulmonary embolisms. Initial efforts to recognise risk of thrombosis in patients on the basis of certain characteristic signs have not been successful, so that general prophylaxis is now fundamentally preferred. Measures of physical prophylaxis of thrombosis have been only partly successful, but the effort required to apply them in practice is out of all proportion to the effect achieved, so that this type of prophylaxis can only be used as a complement to drug therapy and with special high-risk patients. Although anticoagulation is effective, its rate of side effects is so high and the technical difficulties involved are so great that this method cannot be recommended in general prophylaxis of venous thrombosis. This also applies, albeit less dramatically, to thrombose prophylaxis with dextranes; in fact, these must be used with caution only, especially in elderly patients. Completely useless but characterised by considerable side effects is the attempt to achieve venous thrombosis prophylaxis via aggregation inhibitors. Today the standard method in surgery is low-dose heparin prophylaxis according to the effectivity-risk calculation. By applying the conventional non-fractionated heparins according to the low-dose schema it was possible to lower the pulmonary embolism mortality in all surgical disciplines with the exception of traumatology and orthopaedics to one third and the thrombosis rate to one third and the thrombosis rate to one third to one fourth of the original risk.(ABSTRACT TRUNCATED AT 250 WORDS)
鉴于存在10%-60%的血栓形成风险以及1%-5%的致命性肺栓塞风险,目前人们普遍认识到手术中需要进行血栓形成预防。最初试图根据某些特征性体征来识别患者血栓形成风险的努力并未成功,因此现在基本上更倾向于进行全面预防。物理性血栓形成预防措施仅取得了部分成功,但在实际应用中所需的努力与所取得的效果极不相称,因此这种预防措施只能作为药物治疗的补充,用于特殊的高危患者。尽管抗凝治疗有效,但其副作用发生率很高,且涉及的技术难度很大,因此在静脉血栓形成的一般预防中不能推荐使用这种方法。这一点对于右旋糖酐预防血栓形成也适用,尽管程度较轻;事实上,必须谨慎使用右旋糖酐,尤其是在老年患者中。试图通过聚集抑制剂来预防静脉血栓形成是完全无用的,但副作用相当大。如今,手术中的标准方法是根据有效性-风险计算进行低剂量肝素预防。按照低剂量方案应用传统的未分级肝素,可以将除创伤学和矫形外的所有外科领域的肺栓塞死亡率降低至原来的三分之一,血栓形成率降低至原来的三分之一至四分之一。(摘要截取自250字)